Daoxin Ma

5.8k total citations
169 papers, 4.4k citations indexed

About

Daoxin Ma is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Daoxin Ma has authored 169 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 71 papers in Immunology and 58 papers in Hematology. Recurrent topics in Daoxin Ma's work include Acute Myeloid Leukemia Research (30 papers), Immune Cell Function and Interaction (25 papers) and Platelet Disorders and Treatments (16 papers). Daoxin Ma is often cited by papers focused on Acute Myeloid Leukemia Research (30 papers), Immune Cell Function and Interaction (25 papers) and Platelet Disorders and Treatments (16 papers). Daoxin Ma collaborates with scholars based in China, United States and Sweden. Daoxin Ma's co-authors include Chunyan Ji, Xiuwen Wang, Yawei Wang, Baoxia Cui, Shuang Yu, Tian Tian, Ming Hou, Ying Teng, Jingjing Ye and Jun Peng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Daoxin Ma

162 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daoxin Ma China 37 2.0k 1.6k 1.1k 893 827 169 4.4k
Reinhold Munker United States 31 1.4k 0.7× 1.1k 0.7× 1.2k 1.0× 767 0.9× 599 0.7× 119 3.7k
Bo Tang China 31 2.5k 1.2× 1.9k 1.2× 1.1k 0.9× 2.4k 2.7× 828 1.0× 114 6.5k
Eberhard Gunsilius Austria 36 1.6k 0.8× 1.4k 0.9× 786 0.7× 1.6k 1.8× 555 0.7× 135 4.6k
Carmine Selleri Italy 39 1.5k 0.7× 1.4k 0.9× 2.4k 2.1× 1.1k 1.2× 358 0.4× 202 5.4k
Ali Bazarbachi Lebanon 44 1.9k 0.9× 3.7k 2.2× 1.7k 1.5× 1.1k 1.2× 350 0.4× 328 7.3k
Hideki Muramatsu Japan 38 2.5k 1.2× 810 0.5× 1.6k 1.4× 1.0k 1.2× 500 0.6× 274 5.9k
Shaohua Chen China 26 1.0k 0.5× 1.4k 0.9× 536 0.5× 1.2k 1.3× 576 0.7× 184 3.0k
Kenji Oritani Japan 39 2.3k 1.1× 2.4k 1.4× 980 0.9× 1.4k 1.6× 562 0.7× 177 6.3k
C. Arnold Spek Netherlands 41 1.7k 0.8× 946 0.6× 1.5k 1.3× 609 0.7× 485 0.6× 165 5.1k
Neal D. Tolley United States 23 1.5k 0.7× 929 0.6× 1.6k 1.4× 633 0.7× 606 0.7× 35 4.3k

Countries citing papers authored by Daoxin Ma

Since Specialization
Citations

This map shows the geographic impact of Daoxin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoxin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoxin Ma more than expected).

Fields of papers citing papers by Daoxin Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoxin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoxin Ma. The network helps show where Daoxin Ma may publish in the future.

Co-authorship network of co-authors of Daoxin Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Daoxin Ma. A scholar is included among the top collaborators of Daoxin Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoxin Ma. Daoxin Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xinyu, Jinting Liu, Hanyang Wu, et al.. (2024). circFAM193B interaction with PRMT6 regulates AML leukemia stem cells chemoresistance through altering the oxidative metabolism and lipid peroxidation. Leukemia. 38(5). 1057–1071. 11 indexed citations
2.
Sun, Tao, Guosheng Li, Yuan Xia, et al.. (2023). DEX‐Induced SREBF1 Promotes BMSCs Differentiation into Adipocytes to Attract and Protect Residual T‐Cell Acute Lymphoblastic Leukemia Cells After Chemotherapy. Advanced Science. 10(19). e2205854–e2205854. 2 indexed citations
3.
Wang, Dongmei, Tao Sun, Zhe Zhao, et al.. (2023). Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation. Nature Communications. 14(1). 6907–6907. 6 indexed citations
4.
Zhong, Fang, et al.. (2022). Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nature Communications. 13(1). 2522–2522. 135 indexed citations
5.
Zhong, Chaoqin, Ruiqing Wang, Mingqiang Hua, et al.. (2021). NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway. Frontiers in Immunology. 12. 661939–661939. 32 indexed citations
6.
Li, Banban, Wěi Li, Ying Zhou, et al.. (2021). PAK1 Mediates Bone Marrow Stromal Cell-Induced Drug Resistance in Acute Myeloid Leukemia via ERK1/2 Signaling Pathway. Frontiers in Cell and Developmental Biology. 9. 686695–686695. 12 indexed citations
7.
Lu, Fei, Yanan Zhao, Min Ji, et al.. (2020). NLRP3 inflammasome upregulates PD-L1 expression and contributes to immune suppression in lymphoma. Cancer Letters. 497. 178–189. 79 indexed citations
8.
9.
Liu, Qian, Wei Li, Ying Zhou, et al.. (2019). <p>PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway</p>. OncoTargets and Therapy. Volume 12. 10931–10941. 8 indexed citations
10.
Wang, Ruiqing, Chaoqin Zhong, Chen Zhang, Mingqiang Hua, & Daoxin Ma. (2017). Insight to Pharmacokinetics of TKIs: Optimizing Practical Guidelines for Individualized Therapy. Current Drug Metabolism. 18(3). 199–206. 2 indexed citations
11.
Hu, Yu, Xiuwen Wang, Shuang Yu, et al.. (2015). Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia. Expert Opinion on Therapeutic Targets. 19(6). 723–732. 15 indexed citations
12.
Yu, Shuang, Chuanfang Liu, Lan‐Hua Li, et al.. (2014). Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia. Laboratory Investigation. 95(2). 157–167. 57 indexed citations
13.
Tian, Tian, et al.. (2013). Th17 and Treg Cells in Bone Related Diseases. SHILAP Revista de lepidopterología. 2013. 1–10. 37 indexed citations
14.
Wang, Xiangling, Xiaoli Feng, Na Shao, et al.. (2013). Bortezomib and IL-12 produce synergetic anti-multiple myeloma effects with reduced toxicity to natural killer cells. Anti-Cancer Drugs. 25(3). 282–288. 11 indexed citations
15.
Shao, Linlin, Lei Zhang, Yu Hou, et al.. (2012). Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome. PLoS ONE. 7(12). e51339–e51339. 37 indexed citations
16.
Hou, Fei, Zhen Li, Daoxin Ma, et al.. (2012). Distribution of Th17 cells and Foxp3-expressing T cells in tumor-infiltrating lymphocytes in patients with uterine cervical cancer. Clinica Chimica Acta. 413(23-24). 1848–1854. 40 indexed citations
17.
Tian, Yu, Cunzhong Yuan, Daoxin Ma, et al.. (2011). IL-21 and IL-12 Inhibit Differentiation of Treg and TH17 Cells and Enhance Cytotoxicity of Peripheral Blood Mononuclear Cells in Patients With Cervical Cancer. International Journal of Gynecological Cancer. 21(9). 1672–1678. 18 indexed citations
18.
Ma, Daoxin, Jianjian Dai, Xiaojuan Zhu, et al.. (2009). Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. Annals of Hematology. 89(2). 155–161. 14 indexed citations
19.
Zhao, Ping, Daoxin Ma, Fuzhong Xue, et al.. (2009). Seroprevalence and risk factors of human cytomegalovirus infection in the eastern Chinese population. Archives of Virology. 154(4). 561–564. 16 indexed citations
20.
Kong, Beihua, et al.. (2005). High Dose Chemotherapy and Transplantation of Hematopoietic Progenitors from Murine D3 Embryonic Stem Cells. Journal of Chemotherapy. 17(3). 302–308. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reinhold Munker Breakdown of academic impact, for papers by Bo Tang Breakdown of academic impact, for papers by Eberhard Gunsilius Breakdown of academic impact, for papers by Carmine Selleri Breakdown of academic impact, for papers by Ali Bazarbachi Breakdown of academic impact, for papers by Hideki Muramatsu Breakdown of academic impact, for papers by Shaohua Chen Breakdown of academic impact, for papers by Kenji Oritani Breakdown of academic impact, for papers by C. Arnold Spek Breakdown of academic impact, for papers by Neal D. Tolley
Rankless by CCL
2026